bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer

This publication has 19 references indexed in Scilit:

• bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells
  International Journal of Cancer, 1997
• Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-β1 and bcl-2 expression
  International Journal of Cancer, 1996
• Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
  International Journal of Cancer, 1996
• Radiation-induced apoptosis in normal and pre-neoplastic mammary glandsin vivo: Significance of gland differentiation and p53 status
  International Journal of Cancer, 1996
• Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
  Journal of Clinical Investigation, 1995
• Cancer statistics, 1995
  CA: A Cancer Journal for Clinicians, 1995
• Expression of the human BCL‐2 transgene increases the radiation resistance of a hematopoietic progenitor cell line
  Radiation Oncology Investigations, 1994
• Bcl-2 and the regulation of programmed cell death
  The Journal of cell biology, 1994
• Combined Antitumor Effect of Suramin Plus Irradiation in Human Prostate Cancer Cells: The Role of Apoptosis
  Journal of Urology, 1993
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990